Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea

• Published in: International journal of infectious diseases Vol. 141; p. 106961
• Main Authors: Lee, Jaehee, Kim, Dohyang, Hwang, Jinseub, Kwon, Jin-Won
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01-04-2024; Elsevier
• Subjects: Medication possession ratio; South Korea; Tuberculosis; Tuberculosis infection; Tuberculosis preventive therapy; South Korea; Tuberculosis infection; Tuberculosis; Tuberculosis preventive therapy; Medication possession ratio
• ISSN: 1201-9712; 1878-3511
• DOI: 10.1016/j.ijid.2024.02.004

•Half of recently diagnosed tuberculosis (TB) infections (TBI) cases received TB preventive therapy (TPT), primarily with 3 months of treatment with isoniazid and rifampicin.•A total of 1.1% developed active TB in this national TBI cohort over a period of 3.17 years.•TPT generally reduced incident TB risk by 14% in the TBI cohort with varied TB risk.•The non-adherence rates to TPT were 36% for 9 months of treatment with isoniazid, 22% for 4 months of treatment with rifampicin, and 18% for 3 months of treatment with isoniazid and rifampicin.•Adherence to TPT significantly reduced the risk of incident TB as opposed to non-adherence.
Limited evidence exists regarding the impact of adherence to diverse tuberculosis (TB) preventive therapy (TPT) regimens on TB risk in individuals with TB infections (TBIs). This study aimed to examine the association between adherence to three TPT regimens and TB incidence.
This population-based retrospective cohort study used South Korean national health insurance data to identify individuals who were newly diagnosed with TBI between 2015 and 2020. TB incidence was compared among the different TPT regimens used. Treatment adherence was evaluated using the medication possession ratio (MPR).
The study involved 220,483 individuals with TBI, with half undergoing TPT. Over a mean 3.17-year follow-up, 2,430 cases of active TB were observed. TPT was associated with a 14% reduction in TB incidence risk in the entire study population with varying levels of TB risk. Non-adherence (MPR <80%) rates were 36% for 9 months of treatment with isoniazid, 22% for 4 months of treatment with rifampicin, and 18% for 3 months of treatment with isoniazid and rifampicin. Non-adherence to TPT did not lead to a decrease in the risk of TB incidence, whereas adherence to TPT (MPR ≥80%) reduced the risk of TB incidence by up to 72%.
This study reveals increased adherence with shorter TPT regimens in a national TBI cohort, emphasizing the pivotal role of medication adherence in preventing TB.